apple patient
  • Home
  • News
  • Rumors
  • Tips & Tricks
  • Reviews
  • Insights
No Result
View All Result
  • iPhone 18
  • iOS 27
  • iPadOS 27
  • macOS
  • MacBook Neo
  • iPhone 17e
  • AirTags
  • iOS 26
  • iPhone 17
  • MacBook Pro
  • iPadOS
  • iMac
  • Mac mini
  • HomePod
  • Apple TV
  • iPad Pro
  • iPhone Air
  • Apple Vision Pro
  • iPhone 16
  • AirPods 4
  • Apple Watch Ultra
  • HomePod Mini
  • MacBook Air
  • iPad
  • AirPods Max
  • AirPods Pro 3
  • Apple Watch Series 3
  • Mac Studio
  • Studio Display
  • iPad Air
  • iPad mini
  • watchOS 27
  • Apple CarPlay
  • Apple Pay
  • watchOS 26
  • Home
  • News
  • Rumors
  • Tips & Tricks
  • Reviews
  • Insights
No Result
View All Result
apple patient
No Result
View All Result

Apple stock: TD Cowen significantly raises price target to $325

Milan Jovicic by Milan Jovicic
31. October 2025 - 16:18 CET
in Apple News
0
Apple stock iPhone 17 price target

Photo by Unsplash / James A. Molnar

WhatsAppFacebookEmail
Threads

Apple is once again in the spotlight of the financial markets. With the iPhone 17, the company has clearly struck a chord – so much so that investment firms like TD Cowen are significantly revising their expectations upwards. While some analysts remain cautious, the interest in the new iPhone model speaks volumes. Even legal and geopolitical challenges are not changing the overall positive sentiment.

When large investment firms adjust their price targets, there's usually more to it than pure speculation. In Apple's case, it's primarily about strong demand, solid revenue forecasts, and confidence in the company's strategic investment capabilities – even if there's still room for improvement in certain areas like artificial intelligence. TD Cowen is now joining the ranks of the optimists, but with its own distinct tone.

Price target raised to $325

TD Cowen has raised its price target for Apple stock (AAPL) from $275 to $325. This increase of $50 is significantly higher than Evercore 's $10 adjustment. The decision is based on several factors that positively influence the overall outlook.

Despite raising its price target, TD Cowen's tone remains more cautious than that of other analysts. Investments in artificial intelligence are particularly under scrutiny. The assessment is that Apple should do more in this area, even though initial steps are already visible.

iPhone 17 drives demand

The iPhone 17 plays a central role. According to analysts, demand for the device is so high that Apple currently cannot produce enough units to fulfill all orders. TD Cowen interprets the supply difficulties not as a problem, but as a sign of further demand potential.

Apple itself expects these bottlenecks to be resolved by the next quarter. TD Cowen anticipates that higher sales in the coming quarter will offset the increased research and development expenses.

AI investments still have room for improvement

Although Apple has already invested in artificial intelligence, TD Cowen believes this isn't enough to remain competitive in the long run. Back in July 2025, the analysts gave the company 18 months to establish a solid foundation for its "Apple Intelligence" initiative. Three months later, they stand by this assessment – now with only 15 months remaining. Time is running out, but confidence in Apple's ability to deliver appears to be intact.

$1.4 billion expected from tariffs

Apple expects to incur $1.4 billion in customs duties next quarter. TD Cowen acknowledges this but remains unconcerned. Apple is known for structuring its costs in a way that avoids price increases, even under challenging conditions. Analysts consider this ability to mitigate operational risks a significant advantage.

App Store dispute without measurable consequences

The report also mentions the legal disputes surrounding the App Store. However, TD Cowen has not yet seen any concrete impact on revenue. Therefore, while the issue is noted, it is not considered a threat.

Apple impresses despite remaining issues

Apple is delivering solid results, a product in high demand, and demonstrating resilience to external pressures. TD Cowen's increase in its price target to $325 underscores confidence in the company's future – even though there's still room for improvement in AI and strategic clarity.

The combination of high demand, clever cost management, and the prospect of rising revenues continues to make Apple attractive to analysts. Decisions like TD Cowen's demonstrate the strength of their belief in the brand and its products – even in a challenging environment. The best products for you: Our Amazon storefront offers a wide selection of accessories, including those compatible with HomeKit. (Photo by Unsplash / James A. Molnar)

Disclaimer: No recommendation for investments

This article does not constitute financial or investment advice. The information contained herein is for journalistic and informational purposes only. Please conduct your own research or consult a financial advisor before making any investment decisions.

  • Apple stock: Evercore raises price target to $300
  • Apple stock: JP Morgan raises price target to $305
  • No chat monitoring: EU foregoes chat surveillance
  • Apple in leak dispute: New details about Prosser and Ramacciotti
  • WhatsApp is testing its own app for the Apple Watch
  • Apple Q4 2025 Overview – Facts from the Conference Call
  • Apple experiences sales boom: iPhone 17 exceeds expectations
  • Apple struggles with tariffs: Billions in costs in the Christmas quarter
  • Apple confirms: Redesigned Siri will be released in 2026
  • Apple aims for record sales during the Christmas season
  • Apple Q4 2025: Record revenue and strong profit growth
  • China and the USA: No real peace in the trade dispute
  • Bank of America raises price target for Apple to $320
Make Apfelpatient a preferred source One click – and you'll see us more often on Google
Was this article helpful?
YesNo
Tags: Apple ServicesApple IntelligenceiPhoneiPhone 17iPhone AirSiriTechPatient
SendShareSend
Share

Our Amazon Storefront

A handpicked selection of products for iPhone, Mac and more – sorted by topic and updated regularly.

Shop Now

This post contains affiliate links (including Amazon). We earn a small commission on qualifying purchases – at no extra cost to you. Learn more on our Partner Program page.

Previous Post

Apple stock: Evercore raises price target to $300

Next Post

Apple stock: Wedbush raises price target to $320

Milan Jovicic

Milan Jovicic

Milan founded Apfelpatient in 2016 and has been responsible for all editorial content since 2018 — news, rumors, guides, and product reviews. Apple devices here are not test units on loan for two weeks but everyday tools: from the iPhone through MacBook Pro, MacBook Air, and iMac to the Apple Vision Pro, at least one device from nearly every product category is in daily use, many of them replaced annually. Every menu path in a guide is verified on the device before it is published.

Drawn outline of the folded iPhone Ultra with square corners on the hinge side and rounded corners opposite, matching the leaked iPhone Ultra screen protectors

iPhone Ultra: Screen protectors reveal the camera position

August 12, 2026 - 3:58 PM CEST
Glass panel set into the aluminium frame on the back of an iPhone 17 Pro Max in Cosmic Orange, whereas the iPhone 20 glass design is said to wrap the glass around the edges

iPhone 20: Glass design is not supposed to be scrapped after all

August 12, 2026 - 2:50 PM CEST
Jennifer Bailey on stage at an Apple event in front of a projected Apple Card, the Apple Pay chief is leaving the company in October

Apple Pay: Jennifer Bailey is leaving Apple in October

August 12, 2026 - 2:31 PM CEST

About APFELPATIENT

APFELPATIENT brings you the latest Apple news, product updates, guides, reviews and tips across the entire Apple ecosystem — from the iPhone to the Mac to the Apple Vision Pro. From the first rumors to confirmed news: researched responsibly.

Follow Apfelpatient

Facebook Instagram YouTube Threads Threads

Company

  • About Apfelpatient
  • Contact
  • Author Profiles

Community

  • Netiquette
  • Push Notifications
  • RSS feed

Legal

  • Legal Notice
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Affiliate Program

Resources

  • Sitemap

© 2026 Apfelpatient. All rights reserved.

No Result
View All Result
  • Home
  • News
  • Rumors
  • Tips & Tricks
  • Reviews
  • Insights

© 2026 Apfelpatient. All rights reserved. Page Directory

Change language to Deutsch